Fol. Biol. 2023, 69, 81-90
https://doi.org/10.14712/fb2023069030081
Homeobox Protein PROX1 Expression is Negatively Regulated by Histone Deacetylase 1 and c-JUN Complex in MDA-MB-231 Human Breast Cancer Cells
References
1. , J., Osorio, A., Barroso, A. et al. (1997) A region of allelic imbalance in 1q31–32 in primary breast cancer coincides with a recombination hot spot. Cancer Res. 57, 4217-4220.
2. , A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21.
<https://doi.org/10.1101/gad.947102>
3. , Z., Oliver, G. (2002) Prox1 is an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. Mech. Dev. 118, 147-155.
<https://doi.org/10.1016/S0925-4773(02)00240-X>
4. , A. F., Matrisian, L. (1997) Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270.
<https://doi.org/10.1093/jnci/89.17.1260>
5. , M. I., Murphy, G., Birch, M. et al. (1998) Matrix metalloproteinases and metastatic cancer. Biochem. Soc. Symp. 63, 295-313.
6. , C. Q., Chu-LaGraff, Q., Wright, D. M. et al. (1991) The prospero gene specifies cell fates in the Drosophila central nervous system. Cell 65, 451-464.
<https://doi.org/10.1016/0092-8674(91)90463-9>
7. , T., Smits, A., Lindström, M. S. et al. (2012) Transcription factor PROX1: its role in development and cancer. Cancer Metastasis Rev. 31, 793-805.
<https://doi.org/10.1007/s10555-012-9390-8>
8. , W. D., Smith, I. E., Reis-Filho, J. S. (2010) Triple-negative breast cancer. N. Engl. J. Med. 363, 1938-1948.
<https://doi.org/10.1056/NEJMra1001389>
9. , F. (2005) DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev. 15, 490-495.
<https://doi.org/10.1016/j.gde.2005.08.002>
10. , S., Cheng, J., Martinez-Corral, I. et al. (2018) PROX1 is a transcriptional regulator of MMP14. Sci. Rep. 8, 1-13.
<https://doi.org/10.1038/s41598-018-27739-w>
11. , P., Mahajan, V., Lissaman, A. C. et al. (2020) Histone acetylation and the role of histone deacetylases in normal cyclic endometrium. Reprod. Biol. Endocrinol. 18, 84.
<https://doi.org/10.1186/s12958-020-00637-5>
12. , V. M., Saarialho-Kere, U. (1999) Trends in molecular medicine: matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann. Med. 31, 34-45.
<https://doi.org/10.3109/07853899909019260>
13. , C., Shirako, H., Takeuchi, T. et al. (2009) Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15, 195-206.
<https://doi.org/10.1016/j.ccr.2009.01.023>
14. , A., Oliver, G. (2007) Prox1 expression patterns in the developing and adult murine brain. Dev. Dyn. 236, 518-524.
<https://doi.org/10.1002/dvdy.21024>
15. , Y., Zhu, P., Wang, Y. et al. (2015) Antimetastatic therapies of the polysulfide diallyl trisulfide against triple-negative breast cancer (TNBC) via suppressing MMP2/9 by blocking NF-κB and ERK/MAPK signaling pathways. PLoS One 10, e0123781.
<https://doi.org/10.1371/journal.pone.0123781>
16. , Y., Zhang, J.-B., Qin, Y. et al. (2013) PROX1 promotes hepatocellular carcinoma metastasis by way of up‐regulating hypoxia‐inducible factor 1α expression and protein stability. Hepatology 58, 692-705.
<https://doi.org/10.1002/hep.26398>
17. , P. A. (2007) Discovery and development of SAHA as an anticancer agent. Oncogene 26, 1351-1356.
<https://doi.org/10.1038/sj.onc.1210204>
18. , F., Pospich, S., Raunser, S. (2020) Towards a structural understanding of the remodeling of the actin cytoskeleton. Semin. Cell Dev. Biol. 102, 51-64.
<https://doi.org/10.1016/j.semcdb.2019.11.018>
19. , P. N., Troso-Sandoval, T., Rosen, N. et al. (2001) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res. 61, 8492-8497.
20. , X., Ng, H. H., Johnson, C. A. et al. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389.
<https://doi.org/10.1038/30764>
21. , T. V., Mäkinen, T., Mäkelä, T. P. et al. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21, 4593-4599.
<https://doi.org/10.1093/emboj/cdf470>
22. , J., Leder, P. (2002) MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res. 62, 4781-4790.
23. , C. A., Searles, R. G., Melville, A. A. et al. (2009) Prox1 maintains muscle structure and growth in the developing heart. Development 136, 495-505.
<https://doi.org/10.1242/dev.030007>
24. , M., Czarnocka, B. (2020) The impact of transcription factor prospero homeobox 1 on the regulation of thyroid cancer malignancy. Int. J. Mol. Sci. 21, 3220.
<https://doi.org/10.3390/ijms21093220>
25. , M. D., Galeotti, N. (2018) The HDAC1/c-JUN complex is essential in the promotion of nerve injury-induced neuropathic pain through JNK signaling. Eur. J. Pharmacol. 825, 99-106.
<https://doi.org/10.1016/j.ejphar.2018.02.034>
26. , G., Sung, B., Aggarwal, B. B. (2008) TNF: a master switch for inflammation to cancer. Front. Biosci. 13, 5094-5107.
<https://doi.org/10.2741/3066>
27. , E., Yoshida, M. (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6, a018713.
<https://doi.org/10.1101/cshperspect.a018713>
28. , S. Y., Kim, C. G., Jung, Y. J. et al. (2016) The UPR inducer DPP23 inhibits the metastatic potential of MDA-MB-231 human breast cancer cells by targeting the Akt-IKK-NF-κB-MMP-9 axis. Sci. Rep. 6, 34134.
<https://doi.org/10.1038/srep34134>
29. , B., Wigle, J. T., Oliver, G. (2000) Hepatocyte migration during liver development requires Prox1. Nat. Genet. 25, 254-255.
<https://doi.org/10.1038/76996>
30. , M., Lesage, J., Cataldo, D. et al. (2017) EMT and inflammation: inseparable actors of cancer progression. Mol. Oncol. 11, 805-823.
<https://doi.org/10.1002/1878-0261.12095>
31. , B., Felsberg, J., Mikeska, T. et al. (2007) Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer. Int. J. Cancer 121, 547-554.
<https://doi.org/10.1002/ijc.22705>
32. , A. C., Johnstone, R. W. (2014) New and emerging HDAC inhibitors for cancer treatment. J. Clin. Invest. 124, 30-39.
<https://doi.org/10.1172/JCI69738>
33. , J., Kähäri, V. M. (1999) Regulation of matrix metalloproteinase expression in tumour invasion. FASEB J. 13, 781-792.
<https://doi.org/10.1096/fasebj.13.8.781>
34. , J. T., Chowdhury, K., Gruss, P. et al. (1999) Prox1 function is crucial for mouse lens-fibre elongation. Nat. Genet. 21, 318-322.
<https://doi.org/10.1038/6844>
35. , Y., Weinberg, R. A. (2018) Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front. Med. 12, 361-373.
<https://doi.org/10.1007/s11684-018-0656-6>
36. , R. D., Duncan, M. K., Johnson, T. R. et al. (1996) Structure and chromosomal localization of the human homeobox gene Prox 1. Genomics 35, 517-522.
<https://doi.org/10.1006/geno.1996.0392>
